# 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)

> **NCT00145509** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 77 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Asenapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00145509
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145509, "40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00145509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*